The 25 Case Study houses that got built are among the nation’s most iconic examples of mid-century modern architecture.

The high court filing came after an appeals court refused to freeze a judge’s order halting the cuts, which have been led by ...

Sanofi will gain Blueprint's Ayvakit, a treatment for systemic mastocytosis and gastrointestinal stromal tumors, among other therapies in its pipeline.

Sanofi agreed to acquire Blueprint Medicines, a Cambridge, Mass.-based biotech focused on rare immunology diseases, for $9.1 billion in cash and up to $400 million in earnouts. Why it matters: This is ...

Emily Barker and her partner moved to Ireland earlier this year but after three months they have returned to the UK.

Sanofi agreed to buy Blueprint Medicines for up to $9.5 billion, the French drugmaker's biggest move yet to replenish its drug pipeline since it sold a controlling stake in its consumer-healthcare arm ...